Schimmel R J, Honeyman T W, McMahon K K
Biochem J. 1983 May 15;212(2):499-506. doi: 10.1042/bj2120499.
Incorporation of [32P]Pi into phosphatidic acid and phosphatidylinositol of hamster epididymal adipocytes was partially inhibited by 3-isobutyl-1-methylxanthine. This effect of 3-isobutyl-1-methylxanthine was antagonized by isopropyl-N6-phenyladenosine but not by 2',5'-dideoxyadenosine, prostaglandin E1 or clonidine. N6-Phenylisopropyladenosine did not affect incorporation of [32P]Pi into phosphatidic acid or phosphatidylinositol when 3-isobutyl-1-methylxanthine was not present. In contrast with 3-isobutyl-1-methylxanthine inhibition of [32P]Pi incorporation into phospholipids, which was blocked only by N6-phenylisopropyladenosine, accelerated lipolysis was blocked by prostaglandin E1, clonidine and 2',5'-dideoxyadenosine as well as by N6-phenylisopropyladenosine. Phospholipid labelling was also decreased in the presence of adenosine deaminase, but not in the presence of isoprenaline (isoproterenol). The stimulatory effect of N6-phenylisopropyladenosine on [32P]Pi incorporation into phospholipids in cells exposed to 3-isobutyl-1-methylxanthine was evident as soon as 3 min after addition of the adenosine analogue and maximum 10 min after its addition. As observed by others, [32P]Pi incorporation into phospholipids was increased by the alpha 1-selective agonist methoxamine. The stimulatory effect of methoxamine occurred with a time course similar to that of N6-phenylisopropyladenosine and was present at nearly equal magnitude in the absence or presence of 3-isobutyl-1-methylxanthine. The inhibitory effects of 3-isobutyl-1-methylxanthine and adenosine deaminase on phospholipid labelling are attributed to blockade of the action, or to the enzymic removal, of adenosine formed in and released from the fat-cells during their incubation. Supporting this view is the selective reversal of the actions of 3-isobutyl-1-methylxanthine and of adenosine deaminase by N6-phenylisopropyladenosine. These findings suggest an important role for endogenous adenosine in regulation of phospholipid turnover in adipocytes.
[32P]磷酸掺入仓鼠附睾脂肪细胞的磷脂酸和磷脂酰肌醇的过程受到3-异丁基-1-甲基黄嘌呤的部分抑制。3-异丁基-1-甲基黄嘌呤的这种作用被异丙基-N6-苯腺苷拮抗,但不被2',5'-二脱氧腺苷、前列腺素E1或可乐定拮抗。当不存在3-异丁基-1-甲基黄嘌呤时,N6-苯基异丙腺苷不影响[32P]磷酸掺入磷脂酸或磷脂酰肌醇。与3-异丁基-1-甲基黄嘌呤对[32P]磷酸掺入磷脂的抑制作用(仅被N6-苯基异丙腺苷阻断)相反,加速的脂解作用被前列腺素E1、可乐定、2',5'-二脱氧腺苷以及N6-苯基异丙腺苷阻断。在腺苷脱氨酶存在的情况下,磷脂标记也减少,但在异丙肾上腺素存在时则不然。在加入腺苷类似物后3分钟,N6-苯基异丙腺苷对暴露于3-异丁基-1-甲基黄嘌呤的细胞中[32P]磷酸掺入磷脂的刺激作用就很明显,在加入后10分钟达到最大值。如其他人所观察到的,α1选择性激动剂甲氧明可增加[32P]磷酸掺入磷脂。甲氧明的刺激作用发生的时间进程与N6-苯基异丙腺苷相似,并且在不存在或存在3-异丁基-1-甲基黄嘌呤的情况下,其刺激程度几乎相同。3-异丁基-1-甲基黄嘌呤和腺苷脱氨酶对磷脂标记的抑制作用归因于对脂肪细胞在孵育过程中形成并释放的腺苷的作用的阻断或酶促去除。支持这一观点的是N6-苯基异丙腺苷对3-异丁基-1-甲基黄嘌呤和腺苷脱氨酶作用的选择性逆转。这些发现表明内源性腺苷在脂肪细胞磷脂周转调节中起重要作用。